Articles
In this article we will cover the most prominent therapeutic candidates in the alopecia areata treatment industry in 2025. Alopecia Areata Pharmaceutical & Biotech Therapies In Development AnaptysBio – Rosnilimab or ANB030 is a Anti-PD-1 agonist. It is currently being evaluated in a 45 patient phase 2 clinical trial in moderate to severe alopecia areata.…
Read More
The company founded on Alexey Terskikh’s hair multiplication research at the Sanford Burnham Prebys Institute has not had a problem raising capital since its inception a few years ago. In a press release issued today, July, 15, 2021, Stemson Therapeutics announced the closing of a $15 million Series A financing round. DCVC-Bio and Genoa Ventures…
Read MorePerhaps the world’s most famous aging researcher, Dr. David Sinclair of Harvard University, recently revealed that his lab is working on an advanced method for hair restoration. The Sinclair Lab at Harvard Medical School Hair Growth Research Located in Boston, MA, The Sinclair Lab conducts cutting-edge research on the mechanisms of biological aging. The laboratory’s…
Read More
Today, I am pleased to introduce yet another company entering the hair growth treatment industry, Turn Biotechnologies. The company is creating therapies which restore human cells to a more youthful state and has a program targeting skin and hair. Turn Biotechnologies is one of the latest companies to make waves in the anti-aging/aging-reversal sector. The…
Read More
This article continues the recent trend of new company announcements within the hair growth treatment industry. Even better, today’s news involves a new drug entering a phase 1 clinical trial in the US. New Drug Candidate TDM-105795 TechnoDerma Medicines Inc. of China is an early-stage biotech company based in the Zhejiang Province of China. The…
Read More
New research from Stanford University may have uncovered a new useful application for hair restoration surgery. Stanford Stops The Engrailed-1 Last month in April, a research team from Stanford University headed by Dr. Michael Longaker, published a study on scarless wound healing which captured mainstream attention. The peer-reviewed study titled “Preventing Engrailed-1 activation in fibroblasts yields…
Read More
On May 6, 2021 the Swedish biotech company Follicum announced results from its pivotal phase 2 trial which represented the first time its candidate peptide FOL-005 was tested topically to treat male pattern baldness. FOL-005 Grew Hair, But Not Quite Enough To keep things succinct, FOL-005 did not reach its goal in the phase 2…
Read More
In this article we will take a look at two new companies developing therapies for hair growth in 2021. HaplnScience: Targeting The Cause Of Aging In Hair Follicles HaplnScience is a new company developing therapies for age-related diseases including androgenic alopecia, based where else, but South Korea. The company was founded in 2018 by experienced…
Read More
Two prominent US startups have emerged offering online consultations for prescription medicine including topical finasteride. Online Consultations For Topical Finasteride Have you ever wanted to try topical finasteride but did not quite know how to procure it? Well, you now have the opportunity. Two companies in the US, Happy Head and Strut, are now offering…
Read More
Today, we begin a series of articles on new companies entering the hair growth industry. One of these companies, Eirion Therapeutics, has treatments for androgenic alopecia as well as hair graying in their pipeline. Topadur Pharma M119 Based in Switzerland, Topadur Pharma is a clinical stage pharmaceutical company with a focus on the cGMP (cyclic…
Read More